Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial CarcinomaKayo Kikuchi, Toshio Takagi, Takayuki Nakayama et al.|In Vivo|2026Cited by 0